FLAM
CRNX icon

First Light Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

First Light Asset Management’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.6M Sell
1,089,670
-104,593
-9% -$4.67M 3.55% 9
2025
Q4 		$55.6M Buy
1,194,263
+252,747
+27% +$11.3M 4.25% 6
2025
Q3 		$39.2M Buy
941,516
+77,380
+9% +$2.47M 3.7% 6
2025
Q2 		$24.9M Buy
864,136
+8,717
+1% +$269K 3.22% 11
2025
Q1 		$28.7M Sell
855,419
-30,034
-3% -$1.12M 3.28% 11
2024
Q4 		$45.3M Sell
885,453
-58,158
-6% -$3.25M 4.33% 9
2024
Q3 		$48.2M Sell
943,611
-256,897
-21% -$13.2M 4.01% 7
2024
Q2 		$53.8M Sell
1,200,508
-489,669
-29% -$22.6M 4.71% 3
2024
Q1 		$79.1M Sell
1,690,177
-297,595
-15% -$11.6M 6.06% 1
2023
Q4 		$70.7M Buy
1,987,772
+404,443
+26% +$12.4M 5.69% 4
2023
Q3 		$47.1M Buy
1,583,329
+26,107
+2% +$538K 4.47% 6
2023
Q2 		$28.1M Sell
1,557,222
-61,903
-4% -$1.23M 2.2% 15
2023
Q1 		$26M Buy
1,619,125
+289,812
+22% +$5.36M 2.34% 15
2022
Q4 		$24.3M Sell
1,329,313
-17,339
-1% -$306K 2.26% 16
2022
Q3 		$26.4M Buy
1,346,652
+106,043
+9% +$2.16M 2.68% 13
2022
Q2 		$23.1M Buy
1,240,609
+657,842
+113% +$13.1M 2.69% 13
2022
Q1 		$12.8M Buy
582,767
+309,971
+114% +$6.27M 1.13% 29
2021
Q4 		$7.75M Buy
+272,796
New +$6.73M 0.56% 41

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

First Light Asset Management's CRNX Position: Q1 2026 in Review

First Light Asset Management reduced its Crinetics Pharmaceuticals (CRNX) stake by 8.8% in Q1 2026, selling an estimated $4.67M and leaving 1,089,670 shares worth $39.6M. The position accounts for 3.55% of the portfolio, ranked #9.

First Light Asset Management first reported a position in CRNX in Q4 2021 and has held it in 18 quarters since. The position peaked at $79.1M in Q1 2024. 243 funds tracked by Wall St. Rank hold CRNX as of Q1 2026.

  • First Light Asset Management held 1,089,670 shares of Crinetics Pharmaceuticals worth $39.6M as of Q1 2026.
  • First Light Asset Management sold 104,593 Crinetics Pharmaceuticals shares in Q1 2026, an estimated $4.67M.
  • Crinetics Pharmaceuticals made up 3.55% of First Light Asset Management's portfolio in Q1 2026, its #9 holding.
  • First Light Asset Management first reported a position in Crinetics Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • First Light Asset Management's Crinetics Pharmaceuticals position peaked at $79.1M in Q1 2024.
  • 243 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q1 2026.

Based on First Light Asset Management's 13F filing for Q1 2026, filed 15 May 2026.